EE200300005A - Method for diagnosis or detection of conformational disease, required test procedure, reagent kit and apparatus - Google Patents

Method for diagnosis or detection of conformational disease, required test procedure, reagent kit and apparatus

Info

Publication number
EE200300005A
EE200300005A EEP200300005A EEP200300005A EE200300005A EE 200300005 A EE200300005 A EE 200300005A EE P200300005 A EEP200300005 A EE P200300005A EE P200300005 A EEP200300005 A EE P200300005A EE 200300005 A EE200300005 A EE 200300005A
Authority
EE
Estonia
Prior art keywords
diagnosis
detection
test procedure
reagent kit
required test
Prior art date
Application number
EEP200300005A
Other languages
Estonian (et)
Inventor
Soto Claudio
Saborio Gabriella
Original Assignee
Applied Research Systems Ars Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.
Publication of EE200300005A publication Critical patent/EE200300005A/en
Publication of EE05675B1 publication Critical patent/EE05675B1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2828Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200300005A 2000-07-07 2001-06-13 Method for diagnosis or detection of conformational disease, required test procedure, reagent kit and device EE05675B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP00114650 2000-07-07
EP00127892 2000-12-20
EP01102732 2001-02-07
PCT/GB2001/002584 WO2002004954A2 (en) 2000-07-07 2001-06-13 Early diagnosis of conformational diseases

Publications (2)

Publication Number Publication Date
EE200300005A true EE200300005A (en) 2004-08-16
EE05675B1 EE05675B1 (en) 2013-08-15

Family

ID=27223071

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300005A EE05675B1 (en) 2000-07-07 2001-06-13 Method for diagnosis or detection of conformational disease, required test procedure, reagent kit and device

Country Status (31)

Country Link
US (1) US7351526B2 (en)
EP (2) EP1299729B1 (en)
JP (1) JP4790966B2 (en)
KR (1) KR100764981B1 (en)
CN (1) CN1221807C (en)
AR (1) AR029583A1 (en)
AT (2) ATE426816T1 (en)
AU (2) AU6408901A (en)
BG (1) BG66272B1 (en)
BR (1) BRPI0112262B8 (en)
CA (1) CA2413078C (en)
CY (1) CY1109106T1 (en)
CZ (1) CZ304365B6 (en)
DE (2) DE60138146D1 (en)
DK (2) DK1712920T3 (en)
EA (1) EA007391B1 (en)
EE (1) EE05675B1 (en)
ES (2) ES2264691T3 (en)
HK (1) HK1058065A1 (en)
HR (1) HRP20030033B1 (en)
HU (1) HU228813B1 (en)
IL (2) IL153824A0 (en)
MX (1) MXPA03000226A (en)
NO (1) NO331624B1 (en)
NZ (1) NZ523213A (en)
PL (1) PL211154B1 (en)
PT (2) PT1712920E (en)
RS (1) RS51523B (en)
SI (2) SI1712920T1 (en)
SK (1) SK287768B6 (en)
WO (1) WO2002004954A2 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1373904A1 (en) * 2001-03-13 2004-01-02 Eigen, Manfred, Prof. Dr. Method for promoting aggregate formation from protein subunits
US20050026165A1 (en) 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
JP4235544B2 (en) * 2001-05-31 2009-03-11 アドライフ インコーポレーティッド Defect folding protein sensor method
CA2525517C (en) 2003-06-19 2016-05-31 Applied Research Systems Ars Holding N.V. Use of prion conversion modulating agents
DE10328125A1 (en) * 2003-06-23 2005-01-13 Roche Diagnostics Gmbh Detection of protease-resistant prion protein after spontaneous transformation reaction
DE10328830A1 (en) * 2003-06-26 2005-01-20 Roche Diagnostics Gmbh Detection of protease-resistant prion protein after asymmetric interaction
WO2005010533A2 (en) * 2003-07-31 2005-02-03 Hadasit Medical Research Services & Development Ltd. Methods and kits for the detection of prion diseases
NZ545385A (en) 2003-08-13 2010-12-24 Novartis Vaccines & Diagnostic Prion-specific peptide reagents
US20060057671A1 (en) * 2004-09-10 2006-03-16 Orser Cindy S Immobilized probes and methods of detecting conformationally altered prion proteins
JP4568840B2 (en) * 2004-12-28 2010-10-27 国立大学法人金沢大学 Testing method for Alzheimer's disease
JP5048522B2 (en) * 2005-02-15 2012-10-17 エイディーライフ インコーポレイティッド How to detect misfolded proteins and prions
US20060263767A1 (en) * 2005-04-20 2006-11-23 The Board Of Regents Of The University Of Texas System Ultrasensitive detection of prions by automated protein misfolding cyclic amplification
EP1731911A1 (en) * 2005-06-07 2006-12-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method of detecting encephalopathies
DE102005031429A1 (en) * 2005-07-04 2007-01-11 Heinrich-Heine-Universität Düsseldorf Method for the selective determination of pathological protein deposits
AU2006287299B2 (en) 2005-09-09 2012-08-23 Novartis Ag Prion-specific peptoid reagents
US20070281367A1 (en) 2006-05-03 2007-12-06 Applera Corporation Methods, Compositions, and Kits for Quantitating Antibodies
MX2009001079A (en) * 2006-07-28 2009-02-10 Adlyfe Inc Peptide probes for diagnostics and therapeutics.
US20080118938A1 (en) * 2006-09-06 2008-05-22 Lisbell Estrada Methods and Compositions for the Detection of Protein Folding Disorders
US8216788B2 (en) 2007-07-20 2012-07-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Detection of infectious prion protein by seeded conversion of recombinant prion protein
FR2929290B1 (en) * 2008-03-27 2010-05-07 Lfb Biotechnologies METHOD FOR IN VITRO DETECTION AND / OR TITRATION OF NON-CONVENTIONAL TRANSMISSIBLE AGENT
WO2009145195A1 (en) 2008-05-28 2009-12-03 独立行政法人農業・食品産業技術総合研究機構 Method for efficiently amplifying abnormal prion protein derived from bse
JP5209711B2 (en) 2008-05-28 2013-06-12 独立行政法人農業・食品産業技術総合研究機構 Efficient amplification method of abnormal prion protein from sheep scrapie
ITMI20081052A1 (en) * 2008-06-10 2009-12-11 Univ Milano Bicocca LIPOSOMAS ABLE TO EFFECTIVELY TIE THE BETA-AMYLOID PEPTIDE
FR2935711A1 (en) * 2008-09-05 2010-03-12 Lfb Biotechnologies STABLE CELLULAR CLONE EXPRESSING A PRION
EP2496947A1 (en) * 2009-11-04 2012-09-12 Novartis AG Positively charged species as binding reagents in the separation of protein aggregates from monomers
US10215763B2 (en) * 2010-05-18 2019-02-26 Board Of Regents Of The University Of Texas System Methods for estimating prion concentration in fluids and tissue by quantitative PMCA
US10989718B2 (en) 2014-09-11 2021-04-27 Amprion, Inc. Detection of misfolded alpha synuclein protein
US9910049B2 (en) 2014-09-11 2018-03-06 Amprion, Inc. Detection of misfolded amyloid beta protein
IT1405762B1 (en) 2010-11-25 2014-01-24 Icgeb RECOMBINANT PROTEINS WITH SELECTIVE TARGET INACTIVITY ACTIVITIES
US20130288389A1 (en) * 2011-01-18 2013-10-31 Prionics Ag Methods for amplification and detection of prions
FR2973114A1 (en) 2011-03-21 2012-09-28 Ets Francais Du Sang PLASMINOGEN-COATED NANOBILLES AS DIRECT SUPPORT FOR CYCLIC AMPLIFICATION OF PRION PROTEIN PRPSC
WO2013056841A1 (en) 2011-10-19 2013-04-25 Inra (Institut National De La Recherche Agronomique) A method for diagnosing tse
KR101483438B1 (en) * 2014-04-17 2015-01-16 한림대학교 산학협력단 Ultra-efficient Replication Method of Infectious Prions and Device thereof
HRP20231232T1 (en) 2014-09-11 2024-01-19 Board Of Regents Of The University Of Texas System Detection of misfolded proteins
US10359434B2 (en) 2014-10-22 2019-07-23 Colorado State University Research Foundation In vitro detection of prions in blood
WO2016149537A1 (en) 2015-03-17 2016-09-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Bank vole prion protein as a broad-spectrum substrate for rt-quic-based detection and discrimination of prion strains
MX2019013589A (en) 2017-05-16 2020-07-20 Claudio Soto Jara Detection of misfolded tau protein.
US20190353669A1 (en) * 2018-05-16 2019-11-21 Amprion, Inc. Detection of Brain Injury or Neurological Disease using Tau Protein
US11598783B1 (en) 2019-10-23 2023-03-07 Colorado State University Research Foundation In vitro detection of prions
WO2021198098A1 (en) * 2020-04-03 2021-10-07 Universität Zürich Improved method of detecting biomarkers in a biological sample

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262332A (en) * 1989-04-05 1993-11-16 Brigham And Women's Hospital Diagnostic method for Alzheimer's disease: examination of non-neural tissue
US5616871A (en) * 1995-09-28 1997-04-01 Drummond Scientific Company Pipet gun assembly
US5750361A (en) * 1995-11-02 1998-05-12 The Regents Of The University Of California Formation and use of prion protein (PRP) complexes
NZ335290A (en) * 1996-10-15 2001-08-31 D Gen Ltd Diagnosis an typing of spongiform encephalopathy (or bovine spongiform encephalopathy (BSE))
AU5778400A (en) 1999-06-29 2001-01-31 Caprion Pharmaceuticals, Inc. Prion protein binding proteins and uses thereof
JP2003517848A (en) * 1999-12-10 2003-06-03 ミソニクス インコーポレイテッド Ultrasonic angle assembly
US20060263767A1 (en) * 2005-04-20 2006-11-23 The Board Of Regents Of The University Of Texas System Ultrasensitive detection of prions by automated protein misfolding cyclic amplification

Also Published As

Publication number Publication date
CZ304365B6 (en) 2014-04-02
EE05675B1 (en) 2013-08-15
BG66272B1 (en) 2012-11-30
IL153824A0 (en) 2003-07-31
IL153824A (en) 2010-02-17
BRPI0112262B8 (en) 2021-07-27
US20050064505A1 (en) 2005-03-24
ATE335204T1 (en) 2006-08-15
WO2002004954A2 (en) 2002-01-17
EA007391B1 (en) 2006-10-27
NO20030059L (en) 2003-03-07
SI1299729T1 (en) 2006-10-31
AU2001264089B2 (en) 2006-03-30
HRP20030033A2 (en) 2004-02-29
EP1712920B1 (en) 2009-03-25
SK18582002A3 (en) 2003-05-02
HUP0301020A2 (en) 2003-07-28
SI1712920T1 (en) 2009-10-31
DE60121958D1 (en) 2006-09-14
EP1299729A2 (en) 2003-04-09
HK1058065A1 (en) 2004-04-30
CN1449497A (en) 2003-10-15
DK1299729T3 (en) 2006-12-04
WO2002004954A3 (en) 2002-10-24
CA2413078C (en) 2010-08-03
HU228813B1 (en) 2013-05-28
HUP0301020A3 (en) 2010-03-29
AR029583A1 (en) 2003-07-02
DE60138146D1 (en) 2009-05-07
CZ200336A3 (en) 2003-06-18
CN1221807C (en) 2005-10-05
RS51523B (en) 2011-06-30
PT1299729E (en) 2006-10-31
ATE426816T1 (en) 2009-04-15
MXPA03000226A (en) 2004-05-21
HRP20030033B1 (en) 2008-04-30
DK1712920T3 (en) 2009-05-11
DE60121958T2 (en) 2007-02-01
CY1109106T1 (en) 2014-07-02
KR20030036257A (en) 2003-05-09
JP4790966B2 (en) 2011-10-12
YU101202A (en) 2006-01-16
NO20030059D0 (en) 2003-01-06
CA2413078A1 (en) 2002-01-17
PT1712920E (en) 2009-04-09
EP1712920A1 (en) 2006-10-18
JP2004503748A (en) 2004-02-05
PL360397A1 (en) 2004-09-06
SK287768B6 (en) 2011-09-05
ES2322660T3 (en) 2009-06-24
AU6408901A (en) 2002-01-21
NO331624B1 (en) 2012-02-06
EP1299729B1 (en) 2006-08-02
BR0112262A (en) 2003-05-20
ES2264691T3 (en) 2007-01-16
US7351526B2 (en) 2008-04-01
BRPI0112262B1 (en) 2016-08-09
KR100764981B1 (en) 2007-10-09
NZ523213A (en) 2005-01-28
PL211154B1 (en) 2012-04-30
BG107498A (en) 2003-11-28
EA200300126A1 (en) 2003-06-26

Similar Documents

Publication Publication Date Title
EE200300005A (en) Method for diagnosis or detection of conformational disease, required test procedure, reagent kit and apparatus
FI20011877A (en) Method and biosensor for analysis
DE60107322D1 (en) Apparatus and method for normalizing biometric evaluation mass
AU2002346484A1 (en) Method and apparatus for improving the accuracy of alternative site analyte concentration measurements
ITRM20030386A0 (en) DIAGNOSTIC METHOD AND TESTS BASED ON CYTOFLUORIMETRIC ANALYSIS OF ANTIGEN-SPECIFIC T LYMPHOCYTES.
BR0318312A (en) Viral infection foot and mouth disease diagnostic method and Viral infection foot and mouth disease diagnostic kit
PL355271A1 (en) Test strip, an apparatus and as analytic kit for determining analyte concentration as well method of determining concentration of analyte in a physiological sample
FI990559A (en) Sample treatment procedure and diagnostic measuring apparatus
NO20016364D0 (en) Method and apparatus for noninvasive blood analysis
ATE336942T1 (en) DEVICE FOR EXTRACTING BIOLOGICAL LIQUIDS AND MEASUREMENT OF ANALYTES
PL355270A1 (en) Method of determining concentration of analyte in a sample as well as a measuring instrument and its associated apparatus for determining concentration of analyte in a sample
AU2002367597A8 (en) System, method and apparatus for the rapid detection and analysis of airborne biological agents
NO20025702L (en) Two-piece beam FTIR methods and device for use in analyte detection in low transmissivity tests
DE60133982D1 (en) BIOSENSOR AND METHOD FOR ANALYZING BLOOD COMPONENTS
EP1291643A4 (en) Method for measuring fluorescence, apparatus for measuring fluorescence and apparatus for evaluating sample using it
EP1450668A4 (en) Method and apparatus for the detection of neuromuscular disease using disease specific evoked neuromuscular response analysis
ZA200700525B (en) Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same
FR2810444B1 (en) COLLIMATION DEVICE, RADIOLOGY APPARATUS, TEST KIT, AND TESTING METHOD OF RADIOLOGY APPARATUS
AU2003289853A8 (en) Methods, device and instrument for detection of analytes
DE19983966T1 (en) Immunodiagnostic test procedure for an animal disease
FI20015015A0 (en) Method and apparatus for qualitative and quantitative detection of analytes
DE60037595D1 (en) DEVICE FOR NON-DESTRUCTIVE TESTING
NO20024897D0 (en) Method and apparatus for detecting "outliers", biological / pharmaceutical examination experiments
WO2006055422A3 (en) Sampling device and methods
DE50211292D1 (en) ASSAY DEVICE AND METHOD FOR EXAMINING CHEMICAL AND / OR BIOLOGICAL SAMPLES

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
HC1A Change of owner name